Use of opioids or opioid mimetics to treat patients with resistant cancer

• 1. 结合阿片类药物使用棕榈酰基乙醇酰胺 [P] . 中国专利： CN105079811B . 2020.06.23
• 2. 结合阿片类药物使用棕榈酰基乙醇酰胺 [P] . 中国专利： CN105079811A . 2015-11-25
• 3. use of opioids or opioid mimetics to treat resistant cancer patients [P] . BRPI0916555A2 . 2015-11-10

  机译： 使用阿片类药物或阿片类药物来治疗耐药性癌症患者

• 4. Use of opioids or opioid mimetics to treat patients with resistant cancer [P] . 日本专利： JP2011529454A . 2011-12-08

  机译： 使用阿片类药物或类阿片类药物治疗耐药性癌症患者

• 5. USE OF OPIOIDS OR OPIOID MIMETICS FOR THE TREATMENT OF RESISTANT CANCER PATIENTS [P] . CA2732497C . 2017-01-17

  机译： 使用阿片类药物或阿片类药物治疗抗药性癌症患者

• 1. A preliminary report on adjuvant analgesic efficacy of HANS in opioid tolerant patients with cancer pain [J] . Xiaomei Li, Jianhua Zhu, Pingping Li, 中国癌症研究（英文版） . 2014,第002期
• 2. Can palliative radiotherapy influence prostate-specific antigen response in patients with castrate-resistant prostate cancer treated with systemic therapy （chemotherapy or abiraterone）？——a report of three cases [J] . Mohan Hingorani, Sanjay Dixit, Pattu Pugazhenthi, 癌症生物学与医学：英文版 . 2015,第001期
• 3. Can palliative radiotherapy inlfuence prostate-speciifc antigen response in patients with castrate-resistant prostate cancer treated with systemic therapy (chemotherapy or abiraterone)?-a report of three cases [J] . Mohan Hingorani, Sanjay Dixit, Pattu Pugazhenthi, 癌症生物学与医学（英文版 ） . 2015,第001期
• 4. Time to disease-related pain and first opioid use in patients with metastatic castration-resistant prostate cancer treated with sipuleucel-T [J] . E J Small, C S Higano, P W Kantoff, Prostate Cancer and Prostatic Diseases . 2014,第3期
• 5. Prospective Association of Serum Opioid Levels and Clinical Outcomes in Patients With Cancer Pain Treated With Intrathecal Opioid Therapy [J] . Brogan Shane E., Sindt Jill E., Jackman Carina M., Anesthesia and Analgesia: Journal of the International Anesthesia Research Society . 2020,第4期
• 6. A single-center, retrospective analysis evaluating the utilization of the opioid risk tool in opioid-treated cancer patients [J] . MaJ.D., HortonJ.M., HwangM., Journal of pain & palliative care pharmacotherapy . 2014,第1期
• 7. Whole Blood mRNA for Full-Length Neurokinin-1 Receptors in Patients with Chronic Pain Treated with Oral Opioids [C] . T. Azma, Y. Matsubara, K. Yamasaki, International Pain Clinic Congress . 2008
• 8. Understanding the experiences of health care professionals who treat opioid addicted patients with chronic pain. [D] . Chambers, Christina R. 2015
• 9. Time to disease-related pain and first opioid use in patients with metastatic castration-resistant prostate cancer treated with sipuleucel-T [O] . E J Small, C S Higano, P W Kantoff, -1
• 10. Time to disease-related pain and first opioid use in patients with metastatic castration-resistant prostate cancer treated with sipuleucel-T [O] . E J Small, C S Higano, P W Kantoff, 2014
• 11. Novel Approach for Effectively Treating SCI Pain, Improving Opioid Efficacy, and Preventing Opioid Induced Constipation: Key Role of Toll-Like Receptor 4 (TLR4). [R] . Watkins, L. 2016

• 1. Hormone Replacement Therapy for Restoring the HPG Axis in Pain Patients Treated with Long-Term Opioid Analgesics [J] . Srinivas Nalamachu ,Joseph V. Pergolizzi Jr. ,Robert Taylor Jr. . 药理与制药（英文） . 2018,第11期
• 2. Effects of Prophylactic Laxatives for Opioid-Induced Constipation on Constipation Severity and Quality of Life among Patients with Cancer [J] . Mohammad Al-Naeem ,Mohammad Ibrahim Al Qadire ,Jafar Alasad . 护理学期刊（英文） . 2018,第8期
• 3. 单纯强阿片类药物治疗控制癌痛与腹腔内生场热疗联合强阿片类药物治疗控制癌痛的效果比较 [C] . DING Zhao-heng ,丁昭珩 ,YAO Xiao-xiang . 第十三届全国癌症康复与姑息医学大会 . 2017
• 4. 华蟾素联合阿片类药物治疗阿片耐受患者癌痛的临床观察 [A] . 保卫东 . 2019